Drugs that contain Tranexamic Acid

1. Drug name - LYSTEDA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8022106 AMRING PHARMS Tranexamic acid formulations Mar, 2025

(2 years from now)

US8273795 AMRING PHARMS Tranexamic acid formulations Mar, 2025

(2 years from now)

US8487005 AMRING PHARMS Tranexamic acid formulations Mar, 2025

(2 years from now)

US8791160 AMRING PHARMS Tranexamic acid formulations Mar, 2025

(2 years from now)

US8957113 AMRING PHARMS Tranexamic acid formulations Mar, 2025

(2 years from now)

US8809394 AMRING PHARMS Tranexamic acid formulations Mar, 2025

(2 years from now)

US9060939 AMRING PHARMS Tranexamic acid formulations Mar, 2025

(2 years from now)

US7947739 AMRING PHARMS Tranexamic acid formulations Mar, 2025

(2 years from now)

Treatment: Treatment of cyclic heavy menstrual bleeding

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
650MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.